Results of the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA) were analyzed to determine whether a double-blind, placebo-controlled methylphenidate (MPH) titration trial identified the best MPH dose for each child with attention-deficit/hyperactivity disorder (ADHD).
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial
VITIELLO, BENEDETTO;
2001-01-01
Abstract
Results of the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA) were analyzed to determine whether a double-blind, placebo-controlled methylphenidate (MPH) titration trial identified the best MPH dose for each child with attention-deficit/hyperactivity disorder (ADHD).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
grenhill et al.mta.jaacap.2001.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
124.08 kB
Formato
Adobe PDF
|
124.08 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
